American Heart Association (AHA)

The American Heart Association (AHA) funds cardiovascular medical research, educates consumers on healthy living and fosters appropriate cardiac care in an effort to reduce disability and deaths caused by cardiovascular disease and stroke. The AHA also is a key resource for the latest cardiology science through its journals and annual meeting.

Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.
‘Father of modern cardiology’ Eugene Braunwald dies at 96
Colleagues from all over the world have shared loving tributes to Braunwald. ESC President Thomas F. Lüscher, MD, called him "the pioneering cardiologist of his time."
New dyslipidemia guideline puts add-on testing, early screening in the spotlight
The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations.
FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data
The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature.
Public trust in US health agencies falls under Trump—confidence in AHA still quite high
The public has more confidence in the American Heart Association than it does in the FDA, CMS or any other federal health agencies.

As cancer therapies become increasingly targeted and complex, the need for sophisticated cardiovascular monitoring has grown in parallel. Cardiovascular Business spoke with Daniel Addison, MD, director of the cardio-oncology program at The Ohio State University and chair of the American Heart Association’s (AHA) Cardiac Imaging Committee, who said the use of multimodality imaging is transforming how clinicians manage cardiovascular risk in cancer patients and survivors.

Multimodality imaging is more important than ever to the field of cardio-oncology

“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.

TAVR in patients with bicuspid aortic valve stenosis: Does device type matter?

More and more care teams are treating BAV stenosis with TAVR instead of surgical aortic valve replacement. Self-expanding and balloon-expandable valves appear to have their own benefits—as well as their own risks.

cardiologist doctor physician patient black diverse hypertension

New hypertension guidelines embrace early treatment, updated risk assessments and renal denervation

New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.

John Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains how interventional cardiologists can play a role in increasing referrals for coronary artery bypass graft (CABG) surgery for patients who are best suited for the procedure, as opposed to percutaneous coronary intervention (PCI). As the heart team approach expands across cardiology, with surgeons and interventionalists making more decisions together.

How interventional cardiologists can boost cardiac surgery volumes

Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business.

AHA Cardiovascular-Kidney-Metabolic Health Initiative regions as of July 2025.

AHA expands efforts to spread the word about CKM syndrome

This is a rapidly growing area of interest in cardiology as research continues to find close links between heart disease and kidney disease.

Too much screen time is bad for the heart

The excessive use of electronic devices is associated with significant health risks for young children and adolescents. In fact, too much screen time may impact the body in ways that last well into adulthood.

CCTA outperforms TEE after LAAO, new meta-analysis confirms

Researchers reviewed data from more than 1,300 patients who underwent both CCTA and TEE after undergoing LAAO. The two modalities were comparable in many ways, but cardiac CT was linked to a few key benefits.

cardiologists heart doctors heart research heart data

Colchicine reduces risk of some TAVR complications

Giving colchicine to patients prior to TAVR may reduce the risk of certain conduction disturbances, according to new research published in the Journal of the American Heart Association. It does not, however, improve survival.

American Heart Association (AHA)

Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes

‘Father of modern cardiology’ Eugene Braunwald dies at 96

New dyslipidemia guideline puts add-on testing, early screening in the spotlight

FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data

Public trust in US health agencies falls under Trump—confidence in AHA still quite high